Status:
COMPLETED
Hypercapnic Spontaneous Hyperpnoea and Recovery From Sevoflurane Anesthesia
Lead Sponsor:
University Health Network, Toronto
Conditions:
Anesthesia
Surgery
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
The rate of elimination of inhalation agent is directly proportional to the degree of alveolar ventilation. Using Isocapnic Hyperpnoea (IH) device, it is possible to maintain constant end-tidal CO2 wi...
Eligibility Criteria
Inclusion
- elective gynecological surgery
- age 18-80
- ASA I-III
- informed consent
Exclusion
- ASA IV-V,
- contra-indications to sevoflurane anesthesia or other anesthetics included in the protocol
- history of cardiac or respiratory disease
- intracranial pathology
- alcohol or drug abuse
- psychiatric illness and/or medications
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01151267
Start Date
July 1 2009
End Date
October 1 2012
Last Update
February 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital, University Health Network
Toronto, Ontario, Canada, M5G 2C4